Publication | Open Access

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum

Medicine3-Chymotrypsin-like ProteaseImmunologyGlycobiologyAntiviral Drug DevelopmentAntiviral DrugVernonia AmygdalinaViral Structural ProteinPharmacologyInhibitory ActivityDrug DiscoveryStructure-based Virtual Screening